AzTrials
AzTrials

Plantar FascitisMTPNCT06231199

Combined Effect of Foam Roller and Gastrocnemius Release on Plantar Fasciitis

A study testing gastrocnemius release and conventional treatment in people with Plantar Fascitis, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

this study will be conducted to investigate the efficacy of combining foam roller and gastrocnemius release on pain intensity level, dorsi flexion range of motion of ankle joint ,dorsi flexion range of motion of big toe and foot function in subjects with plantar fasciitis. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Plantar Fascitis
What is being tested?
gastrocnemius release and conventional treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
25 Jan 2024to 25 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • aged between 18 years and 60 years
  • heel pain in the morning with first step, insidious sharp pain under the heel, tenderness on medial calcaneus and symptoms decreasing with slight activity (like walking) and worsening toward the end of the day

Who cannot join

  • Infective conditions of foot, tumor, calcaneal fracture
  • Metal implant around ankle
  • Dermatitis, acute sepsis and anesthetic areas
  • Subject with impaired circulation to lower extremities
  • Subject with referred pain due to sciatica
  • Corticosteroids
Show all 9Show fewer
  • Injection in heel preceding 3 month
  • Patient who cannot co-operate
  • history of flat foot

About this study

this study will be conducted to investigate the efficacy of combining foam roller and gastrocnemius release on pain intensity level, dorsi flexion range of motion of ankle joint ,dorsi flexion range of motion of big toe and foot function in subjects with plantar fasciitis.

Read the detailed description

Plantar fasciitis refers to degeneration and inflammation of the proximal plantar fascia. The condition presents with plantar medial heel pain, often exacerbated following periods of inactivity, such as upon waking in the morning.The term "plantar fasciitis" has been quoted for years, but this is a misnomer as inflammatory cells are not present in biopsies from involved fascia. Therefore, advocate the terminology "plantar fasciitis" to explain the syndrome characterized by pain along the proximal plantar fascia and its attachment in the area of the calcaneal tuberosity with function impairment, implying a more chronic degenerative process than acute heel pain.Research found that both stretching and foam rolling techniques helped reduce pain and increase the ROM. However, the effectiveness of foam rolling was superior to stretching in terms of increased pressure pain thresholds (PPTs) at gastrocnemius and soleus. there was a gap in the previous literature in combined effect of gastrocnemius release and foam roller in managing plantar fasciitis and assessing dorsi flexion range of motion of both big toe and ankle joint along with pain assessment and foot function. sixty patients with planter fascitis will be assigned randomly to two groups; first one will receive manual and foam roller release of gastrocnemius and conventional treatment and the other one will receive conventional treatment only.

Being tested
gastrocnemius release, conventional treatment
Keywords
foam roller, gastrocnemius release, plantar fascitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gastrocnemius releaseOther

    The patient will be prone to lying and the therapist will stand at the side of the patient's leg. The therapist uses both hands in cross-hand pattern (Figure 10a and 10b). Myofascial Release will be performed for 20 repetitions, then gastrocnemius release by foam roller;This involved long sitting, with the affected leg will be extended on the foam roller and foot relaxed. The non-affected leg will be flexed at knee so that the foot will be rested on the floor. The participants will be instructed to use their arms and non_affected foot to propel their body back and forth from the popliteal fossa to Achilles tendon in continuous motion. then patients perform plantar fascia realise from standing by foam roller

  • conventional treatmentOther

    the patients will receive conventional treatment in the form of ultrasound therapy (continuous mode/1MHZ) followed by plantar fascia stretch and inctruction

Study groups in NCT06231199
Study groupRoleWhat they receive
gastrocnemius releaseExperimentalthe patients will receive gastrocnemius release manually and by foam roller three times a week for four weeks plus conventional treatment
Receives: Other: gastrocnemius release; Other: conventional treatment
conventional treatmentActive comparatorthe patients will receive conventional treatment three times a week for four weeks
Receives: Other: conventional treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain intensity level

    visual analogue scale will be used for assess pain intensity level. VAS was a 10-cm-long horizontal line with no pain and worst possible pain at the extremes of the line

    Measured: up to four weeks

  2. ankle dorsiflexion

    Electro goniometers are electronic versions of the standard goniometers used in the clinic to measure ankle dorsiflexion ROM

    Measured: up to four weeks

  3. foot function

    The foot function index (questionnaire) will be used to assess foot function. it consists of 23 self-reported items divided into 3 subcategories based on patient values: pain, disability and activity limitation. The patient has to score each question on a scale from 0 (no pain or difficulty) to 10 (worst pain imaginable or so difficult it requires help)

    Measured: up to four weeks

Secondary outcomes (1)
  1. big toe range of motion

    Electro goniometers are electronic versions of the standard goniometers used in the clinic to measure big toe range of motion

    Measured: up to four weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2024
  2. Study start25 Jan 2024 (estimated)
  3. Primary completion25 Apr 2024 (estimated)
  4. Study completion25 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
foam roller combined with gastrocnemius release and conventional treatment
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06231199
Sponsor's protocol ID
P.T.REC/012/004276
Acronym
MTP
Status last verified
Jan 2024
First submitted
21 Jan 2024
Last updated
30 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing gastrocnemius release and conventional treatment in people with Plantar Fascitis, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain intensity level (time frame: up to four weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in